iCure, Stock Price 69,800 KRW (-7.92%)... Bulletin Board 'Bustling'

At this time, posts about iCure are rapidly increasing on portals and stock communities. Today, foreigners have tentatively purchased a net 4,000 shares of iCure, while institutions have sold a net 4,000 shares. iCure is known as a company possessing core technology for transdermal drug delivery systems.

As of 1:30 PM on the 17th, iCure's stock price is 69,800 KRW, down 7.92% from the previous day, with a trading volume of 757,713 shares, which is 60.49% of the 5-day average trading volume. On February 16, iCure became a market issue with the headline "Despite successful Phase 3 clinical trials of dementia patches with Celltrion, stock declines."

In addition to iCure, posts by investors are also rapidly increasing for Showbox (086980), Nivek (138610), and Interpark (035080).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.